開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
Market sources: Saudi-led coalition says it intercepted and destroyed a drone in the eastern region.
2026-10-24
Market sources: Saudi-led coalition says it intercepted and destroyed a drone in the eastern region.
返回
其他消息
2026-10-24
Wall Street Journal, citing US officials familiar with plans, reports US warships stationed in the Middle East are preparing for a potential escalation; if President Trump decides in the coming weeks to order new strikes on Iran, those vessels will be ready to act.
Wall Street Journal, citing US officials familiar with plans, reports US warships stationed in the Middle East are preparing for a potential escalation; if President Trump decides in the coming weeks to order new strikes on Iran, those vessels will be ready to act.
2026-10-24
Conference data published Saturday show Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi cut the risk of death by 58% versus Imfinzi alone in extensive‑stage small‑cell lung cancer. Median overall survival was 21.1 months for the combo versus 12.7 months for Imfinzi monotherapy. Imfinzi is currently the post‑chemotherapy standard for patients without progression after first‑line chemo. Amgen CMO Paul Burton said earlier use of Imdelltra produced greater clinical benefit and called the resul
Conference data published Saturday show Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi cut the risk of death by 58% versus Imfinzi alone in extensive‑stage small‑cell lung cancer. Median overall survival was 21.1 months for the combo versus 12.7 months for Imfinzi monotherapy. Imfinzi is currently the post‑chemotherapy standard for patients without progression after first‑line chemo. Amgen CMO Paul Burton said earlier use of Imdelltra produced greater clinical benefit and called the result unprecedented for advancing treatment in this indication.
Chat with us
, powered by
LiveChat